With significant capital investment in equipment and extensive associated facility modifications, Almac successfully transferred and scaled-up Ironwood Pharmaceuticals’ innovative yet challenging orally delivered peptide product, linaclotide, helping them prepare to meet global demand in multiple territories.
For more information, click here
Related Intelligence and Suppliers
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs